Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
Medicare now covers renal denervation for patients with uncontrolled hypertension
This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.

Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.

Interest rising in CKM syndrome as connections become clearer

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Complications after intravascular lithotripsy are rare, real-world data confirm

Shockwave Medical, now a part of Johnson & Johnson MedTech, has consistently been found safe for patients. However, many previous clinical trials excluded high-risk patients, making it important to track real-world outcomes as time goes on.

Acupuncture improves brain structure in TBI patients

MR imaging shows how acupuncture improves brain structure after TBI

New research suggests acupuncture therapy can improve white matter integrity and help reduce the symptoms associated with severe concussions.

‘This trend is encouraging’: Radial access for PCI now preferred in US

In fact, more than 55% of all PCI cases in 2022 were performed using radial access. Cardiologists are sure to be keeping a close eye on this trend as time goes on.

PET imaging findings support use of intranasal drug delivery for Alzheimer's patients

The discovery is giving researchers vital new information that can be used to develop precision treatments for neurological conditions.

Joseph Turek, MD, PhD, chief of pediatric cardiac surgery at Duke Health

Surgeons perform world’s first on-table heart reanimation to save infant’s life

“This innovation was born out of necessity,” one surgeon explained. “We were determined to find a way to help the smallest and sickest children who previously had no access to DCD heart donation.”

cardiologist Jason H. Rogers, MD, a professor at UC Davis Medical Center in Sacramento, California

Q&A: What Medicare covering TriClip means for heart patients with leaky tricuspid valves

The tricuspid valve has been at the center of several key policy shifts in recent years. In fact, Medicare now covers both T-TEER and TTVR when performed with FDA-approved devices. We spoke to interventional cardiologist Jason H. Rogers, MD, to learn more about how this momentum has impacted patient care.

Experts publish new consensus guidelines on use of CT in patients with long COVID

The statement is intended to standardize terminology, indications for CT use, acquisition parameters and reporting guidelines for patients with long COVID.

Clinical

Patient sues Abbott after early heart valve replacement

FDA clears new AI-enabled coronary plaque analysis software

Evoque TTVR system linked to favorable outcomes in new real-world analysis

First-in-human data highlight IVL’s potential to treat more challenging lesions

Medicare now covers renal denervation for patients with uncontrolled hypertension